ACS Central Science (Apr 2021)
Molecular Aspects Concerning the Use of the SARS-CoV‑2 Receptor Binding Domain as a Target for Preventive Vaccines
- Yury Valdes-Balbin,
- Darielys Santana-Mederos,
- Françoise Paquet,
- Sonsire Fernandez,
- Yanet Climent,
- Fabrizio Chiodo,
- Laura Rodríguez,
- Belinda Sanchez Ramirez,
- Kalet Leon,
- Tays Hernandez,
- Lila Castellanos-Serra,
- Raine Garrido,
- Guang-Wu Chen,
- Dagmar Garcia-Rivera,
- Daniel G. Rivera,
- Vicente Verez-Bencomo
Affiliations
- Yury Valdes-Balbin
- Finlay Vaccine Institute, Havana, Cuba
- Darielys Santana-Mederos
- Finlay Vaccine Institute, Havana, Cuba
- Françoise Paquet
- Centre de Biophysique Moléculaire, Centre National de la Recherche Scientifique UPR 4301, Orléans, France
- Sonsire Fernandez
- Finlay Vaccine Institute, Havana, Cuba
- Yanet Climent
- Finlay Vaccine Institute, Havana, Cuba
- Fabrizio Chiodo
- Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands
- Laura Rodríguez
- Finlay Vaccine Institute, Havana, Cuba
- Belinda Sanchez Ramirez
- Center of Molecular Immunology, Havana, Cuba
- Kalet Leon
- Center of Molecular Immunology, Havana, Cuba
- Tays Hernandez
- Center of Molecular Immunology, Havana, Cuba
- Lila Castellanos-Serra
- Cuban Academy of Sciences, Havana, Cuba
- Raine Garrido
- Finlay Vaccine Institute, Havana, Cuba
- Guang-Wu Chen
- Chengdu Olisynn Biotech. Co. Ltd. and State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, People’s Republic of China
- Dagmar Garcia-Rivera
- Finlay Vaccine Institute, Havana, Cuba
- Daniel G. Rivera
- Laboratory of Synthetic and Biomolecular Chemistry, Faculty of Chemistry, University of Havana, Havana, Cuba
- Vicente Verez-Bencomo
- Finlay Vaccine Institute, Havana, Cuba
- DOI
- https://doi.org/10.1021/acscentsci.1c00216
- Journal volume & issue
-
Vol. 7,
no. 5
pp. 757 – 767
Abstract
No abstracts available.
